Institutional investors purchased a net $5.6 million shares of RGLS during the quarter ended September 2013. This may signal that the smart money is gaining interest in this company as the 34.58% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 2.2 Million shares of Regulus Therapeutics Inc